Bibliotecas PUC-SP - Busca Integrada

Treatment strategies for Middle East respiratory syndrome coronavirus

Por Kayvon Modjarrad
Publicado no Journal of Virus Eradication (2016-01-01)

Ensuring HIV Data Availability, Transparency and Integrity in the MENA Region; Comment on “Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key C...

Por Kayvon Modjarrad, Sten H. Vermund
Publicado no International Journal of Health Policy and Management (2017-12-01)

Opium trade and the spread of HIV in the Golden Crescent

Por Syeda Ayesha Farooq, Mohammad Hafiz Rasooly, Syed Hani Abidi, Kayvon Modjarrad, Syed Ali
Publicado no Harm Reduction Journal (2017-07-01)

Developing Global Norms for Sharing Data and Results during Public Health Emergencies.

Por Kayvon Modjarrad, Vasee S Moorthy, Piers Millett, Pierre-Stéphane Gsell, Cathy Roth, Marie-Paule Kieny
Publicado no PLoS Medicine (2016-01-01)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development

Por Vincent Dussupt, Vincent Dussupt, Vincent Dussupt, Kayvon Modjarrad, Shelly J. Krebs, Shelly J. Krebs, Shelly J. Krebs
Publicado no Frontiers in Immunology (2021-02-01)

A comparative recombination analysis of human coronaviruses and implications for the SARS-CoV-2 pandemic

Por Simon Pollett, Matthew A. Conte, Mark Sanborn, Richard G. Jarman, Grace M. Lidl, Kayvon Modjarrad, Irina Maljkovic Berry
Publicado no Scientific Reports (2021-08-01)

Next generation yellow fever vaccine induces an equivalent immune and transcriptomic profile to the current vaccine: observations from a phase I randomised clinical trialResearch i...

Por Anke Pagnon, Christophe Carre, Marion Aguirre, Emilie Chautard, Sophie Gimenez, Franck Raynal, Emmanuel Feroldi, Paul Scott, Kayvon Modjarrad, Manuel Vangelisti, Nathalie Mantel
Publicado no EBioMedicine (2024-10-01)

Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial

Por Juleen Gayed, Vishva Bangad, Xia Xu, Federico Mensa, Mark Cutler, Özlem Türeci, Uǧur Şahin, Kayvon Modjarrad, Kena A. Swanson, Annaliesa S. Anderson, Alejandra Gurtman, Nicholas Kitchin
Publicado no Vaccines (2024-07-01)

Toward Developing a Preventive MERS-CoV Vaccine—Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabi...

Por Jean-Louis Excler, Christopher J. Delvecchio, Ryan E. Wiley, Marni Williams, In-Kyu Yoon, Kayvon Modjarrad, Mohamed Boujelal, Vasee S. Moorthy, Ahmad Salah Hersi, Jerome H. Kim
Publicado no Emerging Infectious Diseases (2016-08-01)

Community incidence patterns drive the risk of SARS-CoV-2 outbreaks and alter intervention impacts in a high-risk institutional setting

Por Sean M. Moore, Guido España, T. Alex Perkins, Robert M. Guido, Joaquin B. Jucaban, Tara L. Hall, Mark E. Huhtanen, Sheila A. Peel, Kayvon Modjarrad, Shilpa Hakre, Paul T. Scott
Publicado no Epidemics (2023-06-01)

Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice.

Por Rafael A Larocca, Peter Abbink, John D Ventura, Abishek Chandrashekar, Noe Mercado, Zhenfeng Li, Erica Borducchi, Rafael A De La Barrera, Kenneth H Eckels, Kayvon Modjarrad, Michael P Busch, Nelson L Michael, Dan H Barouch
Publicado no PLoS Pathogens (2021-06-01)

Prioritizing interventions for preventing COVID-19 outbreaks in military basic training.

Por Guido España, T Alex Perkins, Simon D Pollett, Morgan E Smith, Sean M Moore, Paul O Kwon, Tara L Hall, Milford H Beagle, Clinton K Murray, Shilpa Hakre, Sheila A Peel, Kayvon Modjarrad, Paul T Scott
Publicado no PLoS Computational Biology (2022-10-01)

Risk of sexually transmitted infections among U.S. military service members in the setting of HIV pre-exposure prophylaxis use.

Por Jason M Blaylock, Evan C Ewers, Elizabeth J Bianchi, David B King, Rosemary O Casimier, Hector Erazo, Stephen Grieco, Jenny Lay, Sheila A Peel, Kayvon Modjarrad, Charmagne G Beckett, Jason F Okulicz, Paul T Scott, Shilpa Hakre
Publicado no PLoS ONE (2023-01-01)

Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas

Por Danielle R. Adney, Lingshu Wang, Neeltje van Doremalen, Wei Shi, Yi Zhang, Wing-Pui Kong, Megan R. Miller, Trenton Bushmaker, Dana Scott, Emmie de Wit, Kayvon Modjarrad, Nikolai Petrovsky, Barney S. Graham, Richard A. Bowen, Vincent J. Munster
Publicado no Viruses (2019-03-01)

rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/be...

Por Thomas P. Monath, Patricia E. Fast, Kayvon Modjarrad, David K. Clarke, Brian K. Martin, Joan Fusco, Richard Nichols, D. Gray Heppner, Jakub K. Simon, Sheri Dubey, Sean P. Troth, Jayanthi Wolf, Vidisha Singh, Beth-Ann Coller, James S. Robertson
Publicado no Vaccine: X (2019-04-01)

Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform.

Por Sidhartha Chaudhury, Jack Hutter, Jessica S Bolton, Shilpa Hakre, Evelyn Mose, Amy Wooten, William O'Connell, Joseph Hudak, Shelly J Krebs, Janice M Darden, Jason A Regules, Clinton K Murray, Kayvon Modjarrad, Paul Scott, Sheila Peel, Elke S Bergmann-Leitner
Publicado no PLoS ONE (2021-01-01)

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein

Por Daiyin Tian, Michael B. Battles, Syed M. Moin, Man Chen, Kayvon Modjarrad, Azad Kumar, Masaru Kanekiyo, Kevin W. Graepel, Noor M. Taher, Anne L. Hotard, Martin L. Moore, Min Zhao, Zi-Zheng Zheng, Ning-Shao Xia, Jason S. McLellan, Barney S. Graham
Publicado no Nature Communications (2017-11-01)

Zika Virus in Rectal Swab Samples

Por Camila Helena Aguiar Bôtto-Menezes, Armando Menezes Neto, Guilherme Amaral Calvet, Edna Oliveira Kara, Marcus Vinícius Guimarães Lacerda, Marcia da Costa Castilho, Ute Ströher, Carlos Alexandre Antunes de Brito, Kayvon Modjarrad, Nathalie Broutet, Patrícia Brasil, Ana Maria Bispo de Filippis, Rafael Freitas Oliveira Franca
Publicado no Emerging Infectious Diseases (2019-05-01)

Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial

Por Oyeniyi Diya, Juleen Gayed, Francine S. Lowry, Hua Ma, Vishva Bangad, Federico Mensa, Jing Zou, Xuping Xie, Yanping Hu, Mark Cutler, Todd Belanger, David Cooper, Xia Xu, Robin Mogg, Özlem Türeci, Uǧur Şahin, Kena A. Swanson, Kayvon Modjarrad, Annaliesa S. Anderson, Alejandra Gurtman, Nicholas Kitchin
Publicado no Infectious Diseases and Therapy (2025-07-01)

Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial

Por Juleen Gayed, Oyeniyi Diya, Francine S. Lowry, Xia Xu, Vishva Bangad, Federico Mensa, Jing Zou, Xuping Xie, Yanping Hu, Claire Lu, Mark Cutler, Todd Belanger, David Cooper, Kenneth Koury, Annaliesa S. Anderson, Özlem Türeci, Uǧur Şahin, Kena A. Swanson, Kayvon Modjarrad, Alejandra Gurtman, Nicholas Kitchin
Publicado no Vaccines (2024-01-01)